Sulforaphane improves cognitive dysfunction after surgery and anesthesia in mice: The role of Keap1-Nrf2 signaling

• Published in: Brain research bulletin 2022-04, Vol.181, p.1-11
• Main Authors: Hua, Dongyu, Luo, Ailin, Wu, Zifeng, Huang, Chaoli, Li, Shan, Xu, Xiaolin, Xu, Jiali, Yang, Chun, Wang, Di, Liu, Cunming
• Format: Article
• Language: English
• Subjects: Anesthesia; Anesthesia, General - adverse effects; Animals; Behavior, Animal - drug effects; Disease Models, Animal; Hippocampus - drug effects; Isothiocyanates - pharmacology; Keap1-Nrf2 signaling; Kelch-Like ECH-Associated Protein 1 - drug effects; Liver - drug effects; Maze Learning - drug effects; Mice; Mouse; NF-E2-Related Factor 2 - agonists; NF-E2-Related Factor 2 - drug effects; Nootropic Agents - pharmacology; POCD; Postoperative Cognitive Complications - drug therapy; Prefrontal Cortex - drug effects; Signal Transduction - drug effects; Sulforaphane; Sulfoxides - pharmacology; Surgery
• ISSN: 0361-9230; 1873-2747
• DOI: 10.1016/j.brainresbull.2022.01.005

Anesthesia and surgery are likely causing cognitive dysfunction in patients, especially the elderly. However, the underlying pathogenic mechanisms largely remain unclear. Accumulating evidence suggest that signaling between Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated protein 1 (Keap1) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays an important role in the pathogenesis and treatment of brain dysfunction, while sulforaphane (SFN), a natural compound acting as an Nrf2 agonist, can improve brain function. In the present study, we used 9-month-old mice to perform tibial fracture surgery under isoflurane general anesthesia. Hierarchical cluster analysis of Morris water maze test (MWMT) analysis was performed to classify mice into post-operative cognitive dysfunction (POCD) versus non-POCD phenotypes. Expression levels of Keap1 and Nrf2 were significantly decreased in the medial prefrontal cortex (mPFC), hippocampus and liver, but not in the nucleus accumbens, muscle and gut of POCD mice compared to control and non-POCD mice. Interestingly, both pretreatment and posttreatment with SFN significantly improved the abnormal behaviors of mice in the MWMT, in parallel with the up-regulated levels of Keap1-Nrf2 signaling in the mPFC, hippocampus and liver. In conclusion, these results suggest that decreased Keap1-Nrf2 signaling in the mPFC, hippocampus and liver may contribute to the onset of POCD, and that SFN exerts facilitating effects on POCD symptoms by increasing Keap1-Nrf2 signaling. •Keap1-Nrf2 decreases in mPFC, hippocampus of brain and liver in POCD model.•Sulforaphane improves abnormal behaviors of POCD.•Sulforaphane restores COPD cognition by increasing Keap1-Nrf2.